Trial
NCT02333149
Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Alberta
Collaborators
The University of Queensland
Condition
Attention Deficit/Hyperactivity Disorder
Intervention
Melatonin
Why stopped
Issues surrounding the current COVID-19 pandemic.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-15